Mounjaro Side Effects for Non-Diabetics: What to Expect (October 2026)

01 · The core answer

Are Mounjaro side effects different if you do not have diabetes?

Most of what you will notice is in the digestive system, because tirzepatide slows how quickly the stomach empties and reduces appetite.¹

Mounjaro is licensed both for weight management and for type 2 diabetes. If you have type 2 diabetes, treatment and monitoring are coordinated differently, so tell your prescriber and your usual diabetes team so care stays joined up.¹

The one area where your situation matters is low blood sugar. Low blood sugar is a risk for people who also take insulin or a sulfonylurea alongside Mounjaro. Our guides cover Mounjaro and hypoglycemia and how Mounjaro affects blood sugar without diabetes.

02 · Your next step

What should you do if you are considering Mounjaro?

Start by checking that you are in the group the medicine is licensed for, then decide how much digestive upset you are prepared to manage in the early weeks. Tell the prescriber about every condition and medicine, because that is how they judge suitability and plan a sensible pace.

03 · Digestive effects

Digestive side effects: what is common and how common

Like all medicines, Mounjaro can cause side effects, and most are digestive. The most common — affecting more than 1 in 10 people — are nausea, diarrhoea, vomiting, constipation and abdominal discomfort.¹ Common effects (up to 1 in 10) include indigestion, reduced appetite, dizziness, reflux, burping, hair shedding and injection-site reactions.¹³

The weight-management trials give a clearer picture of the stomach effects. In the trials supporting Mounjaro's weight-management licence, nausea was reported by 24.6% of people on 5mg, 29.0% on 10mg and 28.0% on 15mg, compared with 8.5% on placebo. Diarrhoea was reported by 18.7% of people on 5mg, 20.8% on 10mg and 22.5% on 15mg, compared with 7.8% on placebo.²

Nausea, vomiting and diarrhoea were more common while the dose was being increased and became less frequent over time.² These are trial figures, so they describe groups of people rather than predicting your own experience. Individual results vary.

Most people who have digestive symptoms describe them as unpleasant but tolerable. The trial data show that a small minority find them hard enough to stop. 1.9% of people on 5mg, 3.3% on 10mg and 4.3% on 15mg stopped treatment permanently because of gastrointestinal side effects, compared with 0.5% on placebo.²

04 · Timeline and dose steps

When side effects start, peak and settle

Most side effects follow a pattern: they appear in the first days after starting or increasing a dose, peak early, and settle as your body adapts. This is one reason Mounjaro uses a gradual dose ladder.¹

That means you can expect a mini-cycle each time the dose rises. The starting pen is 2.5mg, and the strengths then step through 5mg, 7.5mg, 10mg, 12.5mg and 15mg. Each new strength is a fresh adjustment for your gut, so a week that felt easy at the previous dose can still bring symptoms after a step up.

If a new dose is hard to tolerate, prescribers can hold the current dose longer before stepping up. Speak to your clinical team rather than pushing through severe symptoms.¹ This is a legitimate, normal adjustment and not a failure of the treatment.

In SURMOUNT-1, 4.3% of people on 5mg, 7.1% on 10mg and 6.2% on 15mg stopped treatment because of side effects, compared with 2.6% on placebo.² That answers a question many people ask: why do some people stop? Digestive symptoms are the main reason in the trial data, and a slower pace is often the first thing a prescriber will discuss.

05 · Managing symptoms

How to manage nausea, constipation and other everyday effects

Small changes to how you eat help most people. Eat smaller meals slowly, stop at the first feeling of fullness, favour plain lower-fat foods while adjusting, stay well hydrated, and avoid lying down straight after eating.¹ If nausea or vomiting is persistent or you cannot keep fluids down, contact your clinical team — dehydration needs prompt attention.

Constipation

Constipation is very common on Mounjaro for weight management (it may affect more than 1 in 10 people), because food moves through the gut more slowly and many people eat and drink less. What helps: fluid intake first, fibre from vegetables and whole grains, and daily movement.¹ If it persists, a pharmacist can recommend a suitable laxative. Contact your clinical team for pain, bloating or more than a few days without a bowel movement.

Tiredness and low energy

Fatigue is a recognised common side effect, most noticeable in the first weeks and after dose increases. It usually reflects a mix of the body adjusting and simply eating less, so keep meals balanced (protein especially), stay hydrated, and keep gentle activity going. For most people energy returns to normal within a few weeks. Tell your clinical team if tiredness is severe or not settling.¹

Injection-site reactions

Mild redness, itching, a small bruise or a tender lump at the injection site is common and normally settles within a few days. Rotating sites each week and letting the pen warm briefly out of the fridge reduces stinging. Contact your clinical team if a reaction is spreading, hot, very painful, or lasts more than a week.¹³ Follow the instructions supplied with the pen for each injection.

06 · Hair, face and skin

Hair shedding, facial changes and loose skin

Hair loss was reported by 4.9% of people taking tirzepatide in the weight-management trials, compared with 1.0% on placebo. Injection-site reactions were reported by 8.0% of people taking tirzepatide in the weight-management trials, compared with 1.8% on placebo.²

Temporary hair shedding is a recognised side effect. It is linked to rapid weight loss itself rather than a direct drug effect, and for most people it settles as weight stabilises. Protein intake and overall nutrition matter, which is another reason the reduced-calorie diet should stay balanced.¹

"Ozempic face" is not a drug effect. It is what losing a significant amount of weight quickly can do to facial volume, on any method including diet or surgery. The same applies to loose skin. The counter-measures are the ones that protect lean mass: adequate protein, resistance exercise, and a loss pace guided by your prescriber rather than maximum speed. Skin commonly adapts gradually after weight stabilises.¹

07 · Serious side effects

Serious side effects: when to seek urgent help

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis). Seek immediate medical help too for pain in the upper right abdomen, fever or yellowing of skin or eyes (possible gallbladder problems), and for signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing.¹

If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion). Your prescriber may need to adjust those medicines.¹ Do not stop other medicines on your own; speak to the prescriber first.

Report any suspected side effect through the MHRA Yellow Card scheme as well as telling your prescriber.¹⁹ If you notice a new or lasting symptom, tell your prescriber about it.

08 · Mood, kidneys and thyroid

Mood, kidneys, liver and thyroid questions

Regulators have looked specifically at whether GLP-1 medicines are linked to low mood or suicidal thoughts. The EMA's safety committee reviewed the evidence and concluded in 2024 that it does not support a causal link, and the MHRA keeps this under continuous review.¹⁷ That said, any big change in weight, appetite and routine can affect how you feel. Tell your prescriber about any history of depression, and seek help promptly if your mood drops or you have distressing thoughts during treatment.

If you have thoughts of harming yourself or ending your life, get help straight away. Call 999 or go to A&E if you are in immediate danger. In England you can call NHS 111 and choose the mental health option, any time. You can also call Samaritans free on 116 123, day or night. Tell your prescriber about any change in your mood while taking Mounjaro.

On the kidneys and liver, Mounjaro is not known to damage either directly, and no dose adjustment is needed for mild to moderate kidney or liver impairment. The practical risk is indirect: severe vomiting or diarrhoea can cause dehydration, which can strain the kidneys. Keep fluids up and get medical help straight away if you cannot keep fluids down. People with severe impairment need individual prescriber assessment.¹

In rodent studies tirzepatide caused thyroid C-cell tumours. It is not known whether this applies to humans, and no increase has been shown in human trials. As a precaution, tell your prescriber if you or a close relative have had medullary thyroid cancer or the inherited condition MEN 2. Routine thyroid monitoring is not required for most people.¹

09 · Who should avoid it

Who should not take Mounjaro

Mounjaro is not suitable for everyone. You should not take it if you are allergic to tirzepatide or any of its ingredients, and it should not be used during pregnancy or while trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly. Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems.¹ Always share your full medical history and medicine list during consultation.

For a wider look at risk, read our guide on whether Mounjaro is safe for weight loss in non-diabetics. For the bigger picture of this medicine class, see GLP-1 drugs for non-diabetics.

10 · Long-term and stopping

Long-term effects and what happens when you stop

Most side effects are a feature of the early weeks and the dose steps rather than a long-term problem. In trials, weight loss on tirzepatide came with average improvements in waist size, blood pressure, cholesterol and blood-sugar measures, and most participants with prediabetes returned to normal blood-sugar levels. These are trial-average secondary outcomes, not promises.² Our page on Mounjaro long-term side effects covers this further.

If you stop, the medicine does not leave at once. After a final dose it takes four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹ If you have type 2 diabetes and are thinking of stopping, speak to your diabetes team first, since they manage your blood sugar plan. If you stop, regaining weight is possible: in SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, so plan stopping with your prescriber.